Guiding our client to develop and successfully register a third-generation vaccine

Categories

22 May 2023

Advancing Medical Breakthroughs: World’s Largest Human Imaging Project to Rescan 60,000 UK Volunteers

Introduction:  In a ground-breaking endeavour, the world's largest human imaging project is gearing up to embark on an...

Read Insight
15 May 2023

Workshops, seminars, and networking: Cannabis Europa 2023

I had the pleasure of attending the Cannabis Europa conference in London on 3rd May, and it was...

Read Insight
12 May 2023

Study reveals medicinal cannabis ‘safe and effective’ pain relief for cancer patients

The use of medicinal cannabis as a complementary treatment for cancer patients has gained significant attention in recent...

Read Insight
25 April 2023

BIO KOREA 2023 International Convention

BIO KOREA 2023 is just around the corner and Woodley BioReg is delighted to announce that we will...

Read Insight
20 April 2023

Cannabis Europa 2023: Driving the market forward

Woodley BioReg is thrilled to be attending Cannabis Europa at the Barbican Centre in London on 2-3 May...

Read Insight
13 April 2023

NHS England and Wales Offer Treatment for Inherited Cancers

This week marks a major development for patients with inherited breast or prostate cancer in England and Wales,...

Read Insight
07 April 2023

We’re proud to be celebrating our 22nd year in business

Woodley BioReg is celebrating its 22nd year of providing excellence in bioregulatory services and solutions to the pharmaceutical,...

Read Insight
03 April 2023

Is AI the future of cancer research?

The recent discovery that artificial intelligence (AI) is able to detect the presence of breast cancer up to...

Read Insight
27 March 2023

WBR Appoints Stephen Park as New Sales and Business Development Manager

Woodley BioReg is pleased to announce the appointment of Stephen Park as our new Sales and Business Development...

Read Insight